1. Life Sciences Intellectual Property and Patent Litigation Excellence
Patent disputes are among the most high-stakes battles in the life sciences sector, where years of research and billions in investment often rest on a single patent claim. SJKP LLP represents clients in high-profile pharmaceutical, biologic, biosimilar, and medical device litigation. Our team has extensive experience in district courts, appellate courts, and international tribunals, helping clients secure market exclusivity and defend against aggressive generic challenges.
Life Sciences Intellectual Property and Hatch-Waxman Litigation
We have deep experience in Abbreviated New Drug Application (ANDA) litigation, leveraging the Hatch-Waxman Act to protect brand-name exclusivity or challenge invalid patents. Our attorneys handle Paragraph IV certifications, Orange Book listings, and litigation strategies that balance commercial priorities with regulatory compliance.
Life Sciences Intellectual Property and Ptab Proceedings
Our attorneys have secured victories in inter partes review (IPR) and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board. By aligning USPTO challenges with broader litigation strategies, we help clients defend core patents or clear the way for generic entry, always with an eye toward minimizing risk and maximizing commercial outcomes.
2. Life Sciences Intellectual Property and Trade Secrets Protection
In biotechnology and pharmaceuticals, trade secrets such as formulations, cell lines, and proprietary processes often represent a company’s most valuable assets. We defend vital bioscience know-how against misappropriation through swift injunctions, forensic tracing, and aggressive enforcement actions. Our team develops proactive strategies to safeguard confidential information before disputes arise.
Life Sciences Intellectual Property and Competitive Intelligence Safeguards
Trade secret theft frequently involves departing employees, academic collaborators, or joint venture partners. We design confidentiality frameworks, exit protocols, and monitoring systems to reduce leakage risks. In disputes, we act quickly to obtain injunctions and recover damages, protecting innovation from competitive exploitation.
Life Sciences Intellectual Property and Cross-Border Enforcement
With a global footprint, SJKP LLP addresses international misappropriation involving multinational corporations, cross-border labs, and international licensing partners. We coordinate enforcement actions across jurisdictions, navigate conflicting laws, and partner with local counsel to ensure effective protection in every market.
3. Life Sciences Intellectual Property and Product Life Cycle Strategy
Maximizing the commercial life of a drug or device requires careful management of IP and regulatory exclusivities. We advise clients on patent term extensions, regulatory exclusivity frameworks, and portfolio layering strategies that protect innovation long after the initial patent expires.
Life Sciences Intellectual Property and Regulatory Exclusivities
Our team counsels on U.S. .nd international protections, including orphan drug exclusivity, pediatric extensions, and BPCIA biologics exclusivities. We design strategies that combine patents with regulatory rights, extending market access and delaying generic competition.
Life Sciences Intellectual Property and Portfolio Development
From early-stage R&D to late-stage commercialization, we help clients construct layered patent portfolios. These portfolios cover composition of matter, methods of use, formulations, and manufacturing processes, ensuring comprehensive protection and maximizing return on innovation.
4. Why Sjkp Llp for Life Sciences Intellectual Property?
Our team includes attorneys with advanced scientific training, engineers, biochemists, and molecular biologists, who understand the science behind the law. This interdisciplinary strength allows us to anticipate technical challenges in litigation, draft precise patent claims, and communicate effectively with regulators, courts, and industry experts.
Life Sciences Intellectual Property and Trial Readiness
We maintain a trial-first mindset, preparing every case as if it will go before a jury. This approach has secured favorable outcomes in both jury trials and appellate litigation, enabling clients to either win decisively or negotiate superior settlements.
Life Sciences Intellectual Property and Global IP Coordination
Innovation is global, and so are we. SJKP LLP coordinates patent enforcement, licensing, and compliance strategies across the U.S., EU, China, and Japan. Our integrated teams ensure that IP protection aligns with each jurisdiction’s legal landscape and commercial priorities.
Life Sciences Intellectual Property and IP-Driven Transactions
From licensing agreements to IPOs and cross-border M&A, intellectual property often drives deal value. We advise clients on the IP dimensions of financing, strategic partnerships, and acquisition activities, ensuring that IP assets are properly valued, secured, and monetized.
01 Jul, 2025
